XBiotech Inc. (XBIT) is a Biotechnology company in the Healthcare sector, currently trading at $2.46. It has a SharesGrow Score of 53/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Valuation: XBIT trades at a trailing Price-to-Earnings (P/E) of -1.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.03.
Net income is $46M (loss), growing at -16.6%/yr. Net profit margin is 0% (thin). Gross margin is 83.8% (+0 pp trend).
Balance sheet: total debt is $0 against $140M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 16.01 (strong liquidity). Debt-to-assets is 0%. Total assets: $150M.
Analyst outlook: 3 / 3 analysts rate XBIT as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 15/100 (Fail), Past 0/100 (Fail), Health 67/100 (Partial), Moat 46/100 (Partial), Future 100/100 (Pass), Income ?/100 (Fail).
